News

EDUFLUVAC Workshop on immunoassay standardisation for universal flu vaccines22 June 2015

The first EDUFLUVAC workshop on immunoassay standardisation for universal flu vaccines took place on 18-19 June 2015 at the National Institute for Biological Standards and Control (NIBSC), UK.  This workshop was co-organised and co-sponsored by the National Institute of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID), USA.

BELLEROPHON Call for process development and GMP manufacture of a vaccine candidate17 June 2015

BELLEROPHON would like to make a call for the process development and production in E. coli according to Good Manufacturing Practice (GMP) of a protein vaccine candidate to be used in toxicological and phase I studies.  The subcontracting is expected in Q4 2015.

MVVC/MVVC 2 meeting, Oxford 4 - 5 March 201517 June 2015

The annual meeting of MVVC / MVVC 2 held in Oxford in March is mentioned in the EDCTP May news letter (page 6).  Field trials of a new combination malaria vaccine, which are an integral part of the MVVC2 project, are funded by among others EDCTP.

EVI Rendez-Vous 201513 June 2015

Want to learn more about what EVI is doing, then join us for the 2015 Rendez-Vous on 9 December.

It is an increasing popular event, bringing together people from all corners of the scientific community, the European Commission and other like funders.

JAIVAC phase I clinical trial results published02 June 2015

The results of JAIVAC phase I clinical trial of a recombinant blood stage vaccine candidate for plasmodium falciparum malaria based on MSP1 and EBA175 were published in PLOS one in April 2015.
This project was supported financially by the Department of Biotechnology and Irish Aid.

EVI has currently two exciting career opportunities26 May 2015

Vaccine Management Assistant - new deadline 5 June 2015 17:00 CET.  Download PDF-version

An eighteen month junior position for a motivated individual for a phase I vaccine clinical trial.

Project Manager - deadline 15 June 2015 17:00 CET.  Download PDF-version

A three year junior position to work with international partners.

EVI would like to thank all those who applied for these positions, and for their interest in EVI.


MVVC: Publication of promising results from a recent vaccine clinical trial in Kenya10 May 2015

Results of a phase IIb clinical trial conducted in Kenya under the MVVC project were published 7 May 2015 in Science Translational Medicine.
Press release here

World Malaria Day 2015: We can further bring down deaths from malaria by concerted global action25 April 2015

‘European Vaccine Initiative urges to sustain funding and political commitment to ensure continued success in combatting malaria’.

EURIPRED: Call for application for Free Services13 April 2015

European Research Infrastructures for Poverty Related Diseases (EURIPRED)

News letter April 2015

Call for application for Free Services.  Deadline: 12 May 2015

4th MultiMalVax consortium meeting27 March 2015

The MultiMalVax consortium will meet for the fourth time during the next annual meeting on 17-18 November 2015.  The meeting will be hosted by GlaxoSmithKline, Belgium.  Project progress and future activities will be discussed.

EVI staff participants: Nicolas Havelange, Sophie Houard, Sophia Hundt, Nathalie Imbault, Odile Leroy, Nicola Viebig